IT8021498A0 - Sali misti di amminoacidi essenziali o semi-essenziali e loro analoghi non azotati, nonche' loro impiego nella terapia di disfunzioni renali ed epatiche. - Google Patents

Sali misti di amminoacidi essenziali o semi-essenziali e loro analoghi non azotati, nonche' loro impiego nella terapia di disfunzioni renali ed epatiche.

Info

Publication number
IT8021498A0
IT8021498A0 IT8021498A IT2149880A IT8021498A0 IT 8021498 A0 IT8021498 A0 IT 8021498A0 IT 8021498 A IT8021498 A IT 8021498A IT 2149880 A IT2149880 A IT 2149880A IT 8021498 A0 IT8021498 A0 IT 8021498A0
Authority
IT
Italy
Prior art keywords
essential
nitrogenous
analogues
kidney
therapy
Prior art date
Application number
IT8021498A
Other languages
English (en)
Other versions
IT1141482B (it
Inventor
Walser Mackenzie
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Publication of IT8021498A0 publication Critical patent/IT8021498A0/it
Application granted granted Critical
Publication of IT1141482B publication Critical patent/IT1141482B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT21498/80A 1979-04-18 1980-04-18 Sali misti di amminoacidi essenziali o semi-essenziali e loro analoghi non azotati,nonche' loro impiego nella terapia di disfunzioni renali ed epatiche IT1141482B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/031,274 US4296127A (en) 1979-04-18 1979-04-18 Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof

Publications (2)

Publication Number Publication Date
IT8021498A0 true IT8021498A0 (it) 1980-04-18
IT1141482B IT1141482B (it) 1986-10-01

Family

ID=21858554

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21498/80A IT1141482B (it) 1979-04-18 1980-04-18 Sali misti di amminoacidi essenziali o semi-essenziali e loro analoghi non azotati,nonche' loro impiego nella terapia di disfunzioni renali ed epatiche

Country Status (16)

Country Link
US (1) US4296127A (it)
JP (1) JPS6024094B2 (it)
BE (1) BE882833A (it)
CA (1) CA1139768A (it)
DE (1) DE3015076A1 (it)
DK (1) DK159147C (it)
ES (1) ES8102804A1 (it)
FI (1) FI70206C (it)
FR (1) FR2454434A1 (it)
GB (1) GB2048867B (it)
IE (1) IE49586B1 (it)
IT (1) IT1141482B (it)
LU (1) LU82369A1 (it)
NL (1) NL191583C (it)
NO (1) NO155239C (it)
SE (1) SE460902B (it)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61501558A (ja) * 1984-01-16 1986-07-31 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテッド 中および長鎖トリグリセライドの非経口栄養補給
DE3438455A1 (de) * 1984-10-19 1986-06-26 Institut Dr. Ziegler, Bettingen L-lysin- und l-histidinpyruvat
US4677121A (en) * 1985-01-22 1987-06-30 The Johns Hopkins University Method of inhibiting muscle protein degradation
US4752619A (en) * 1985-12-23 1988-06-21 The Johns Hopkins University Nutritional supplement for treatment of uremia
US4871552A (en) * 1986-09-25 1989-10-03 W. R. Grace & Co.-Conn. Hydantoins as animal food supplements
US4744990A (en) * 1986-09-25 1988-05-17 W. R. Grace & Co. Hydantoins as animal food supplements
FR2615734B1 (fr) * 1987-05-27 1989-12-01 Synthelabo Compositions pharmaceutiques contenant un melange de sels de cetoacides et d'amino-acides utiles pour le traitement de l'uremie
FR2618331B1 (fr) * 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
JP2522034B2 (ja) * 1988-12-27 1996-08-07 味の素株式会社 α−ケト酸・アミノ酸塩化合物及びその製造方法
US4957938A (en) * 1989-06-21 1990-09-18 Abbott Laboratories Nutritional formulation for the treatment of renal disease
DE3936319C3 (de) * 1989-11-01 1997-05-07 Bartz Volker Phosphatbinder zur oralen Verabreichung
DE3940052A1 (de) * 1989-12-04 1991-06-06 Nephro Medica Pharma Dialysier- und spuelloesung zur intraperitonealen verabreichung
DE3943424A1 (de) * 1989-12-30 1991-07-04 Nephro Medica Pharma Infusions- und injektionsloesung zur intravenoesen verabreichung
US5234696A (en) * 1991-12-27 1993-08-10 Abbott Laboratories Method of producing tablets, tablets produced thereby, and method of treatment using same
US5256697A (en) * 1992-04-16 1993-10-26 Abbott Laboratories Method of administering pyruvate and methods of synthesizing pyruvate precursors
US5276018A (en) * 1992-07-17 1994-01-04 Brigham And Women's Hospital Composition comprising amino acids and methods for decreasing muscle breakdown
US20070141181A1 (en) 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6797289B2 (en) 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
EP1056464A1 (en) 1998-02-27 2000-12-06 Nutramax Laboratories, Inc. L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
US20010000472A1 (en) * 1998-02-27 2001-04-26 Nutramax Laboratories, Inc. L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
US8680329B2 (en) * 2010-10-13 2014-03-25 Tianjin Tiancheng Pharmaceutical Co., Ltd. (China) Process for preparation of α-ketoglutaric acid
US8754256B2 (en) * 2010-10-13 2014-06-17 Tianjin Tiancheng Pharmaceutical Co., Ltd. (China) Process for preparation of L-Arginine α-ketoglutarate 1:1 and 2:1
US20140187815A1 (en) * 2012-12-28 2014-07-03 Guoji Zhang Process for preparation of l-arginine alpha-ketoglutarate 1:1 and 2:1
JP2022527582A (ja) * 2019-04-11 2022-06-02 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング ケト酸を含む細胞培養培地

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2457820A (en) * 1945-12-27 1949-01-04 Merck & Co Inc Amino acid solution and process for preparing the same
US3441650A (en) * 1965-07-23 1969-04-29 Lab Jacques Logeais Sa Therapy of ammonical intoxications by di-l-ornithine alpha-ketoglutarate
US3764703A (en) * 1969-11-07 1973-10-09 Astra Ab Amino acid mixture for use in treatment of uremic conditions
DE2335215B2 (de) * 1972-07-13 1979-04-05 The Johns Hopkins University, Baltimore, Md. (V.St.A.) Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen
GB1442154A (en) * 1973-04-30 1976-07-07 Walser M Composition for promotion of protein synthesis and suppression of urea formation in the body
US4100293A (en) * 1974-04-15 1978-07-11 The Johns Hopkins University Treatment of hepatic disorders with therapeutic compositions comprising keto analogs of essential amino acids
GB1511302A (en) * 1974-04-15 1978-05-17 Univ Johns Hopkins Pharmaceutical compositions comprising amino acid analogues
FR2315916A2 (fr) * 1976-03-23 1977-01-28 Univ Johns Hopkins Melanges therapeutiques comprenant des analogues alpha hydroxy acides d'acides amines essentiels et leur administration a l'homme en vue de l'amelioration de la synthese proteique et la suppression de la formation d'uree
DE2759133A1 (de) * 1976-12-31 1978-07-13 Carmelo Prof Giordano Gemisch essentieller aminosaeuren und/oder analoger ketosaeuren und verwendung derselben diaetzusatz bei niereninsuffizienz
US4228099A (en) * 1978-03-17 1980-10-14 The Johns Hopkins University Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders

Also Published As

Publication number Publication date
NL8002297A (nl) 1980-10-21
DE3015076A1 (de) 1980-10-30
IE49586B1 (en) 1985-10-30
NL191583C (nl) 1995-10-03
GB2048867A (en) 1980-12-17
IT1141482B (it) 1986-10-01
FR2454434B1 (it) 1984-02-24
NL191583B (nl) 1995-06-01
NO155239C (no) 1987-03-04
DK159147C (da) 1991-02-11
NO155239B (no) 1986-11-24
JPS6024094B2 (ja) 1985-06-11
LU82369A1 (fr) 1980-07-31
CA1139768A (en) 1983-01-18
SE460902B (sv) 1989-12-04
ES490649A0 (es) 1981-02-16
DK163180A (da) 1980-10-19
DK159147B (da) 1990-09-10
GB2048867B (en) 1983-03-16
BE882833A (fr) 1980-08-18
FI70206B (fi) 1986-02-28
IE800781L (en) 1980-10-19
SE8002900L (sv) 1980-12-12
FI70206C (fi) 1986-09-15
DE3015076C2 (it) 1988-01-21
FR2454434A1 (fr) 1980-11-14
US4296127A (en) 1981-10-20
FI801225A (fi) 1980-10-19
JPS5653641A (en) 1981-05-13
NO801119L (no) 1980-10-20
ES8102804A1 (es) 1981-02-16

Similar Documents

Publication Publication Date Title
IT8021498A0 (it) Sali misti di amminoacidi essenziali o semi-essenziali e loro analoghi non azotati, nonche' loro impiego nella terapia di disfunzioni renali ed epatiche.
IT1151031B (it) Composizione per pulitura,in particolare per l'eliminazione di fondente per saldatura
IT1131386B (it) Particelle sferiche di carbone attivato adatte all'impiego in composizioni farmaceutiche contro le intossicazioni
IT7921071A0 (it) Sali di ornitina ed arginina di chetoacidi a catena ramificata eloro impiego nel trattamento di disfunzioni epatiche e renali.
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
JPS5231839A (en) Drug for cosmetics and permanent wave in combination
IT8919876A0 (it) Composizioni farmaceutiche agenti in particolare sul cuore e sul cuore e sul sistema cardiovascolare e procedimento per la loro preparazione.
IT1146993B (it) Perfezionamento nelle spolette di prossimita'
IT8119242A0 (it) Nuovi derivati della 3,4,5-trimetossicinnamoilpiperazina , loro sali, loro procedimento di preparazione e loro applicazione in terapia.
IT7925706A0 (it) Uso di glicerilfosforilderivati nella terapia di dislipemie ed epatiti, e composizioni farmaceutiche relative.
IT7921079A0 (it) Composizioni protettive per superfici d'acciaio e processo per la loro preparazione.
IT8984980A0 (it) Procedimento per la realizzazione di cingoli in gomma e cingolo cosi'.
ES2074623T3 (es) Utilizacion de aminoacidos para la proteccion de tejidos cardiacos isquemicos y su recuperacion metabolica.
CA2206566A1 (en) Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds
IT1053335B (it) Perfezionamento nelle ruote di lancio per operazioni di pallinatura martellatura e simili
IT1175920B (it) Impiego di 1,4-diidropiridine in prodotti antiarteriolerosi e loro preparazione
BR8403770A (pt) Concentrado,composicao de tratamento de materiais do solo e processo para o tratamento de materiais do solo
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
IT8323601A0 (it) Impiego di ibuprofene e flurbiprofene nella cura dell'erpete.
IT1070097B (it) Diidromicina e suoi sali come antibiotici particolarmente per uso zootecnico...e procedimento per la loro preparazione
IT1059875B (it) Benzodiossani 1..4 loro procedimento di preparazione e loro applicazione in terapia
NL950003I2 (nl) In water oplosbare zouten van 2,4-diamino-5-methyl-6-Ä(3,4,5-tri-methoxyanilino)metylÜ chinazoline, samenstellingen, die dergelijke zouten bevatten ende bereiding van dergelijke zouten.
DE3473826D1 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
IT8322785A0 (it) Metodo e composizione per il trattamento di tumori.
IT1060568B (it) 3 amino 4 carbalcossibenzo 4 fenos sianilidi processo per la loro preparazione e loro impiego

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970430